Skip to main content
    T

    Tenaya Therapeutics Inc (TNYA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.32
    -0.01 (-3.24%)

    Market Cap: $79.59M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    Tenaya Therapeutics Inc (TNYA) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Tenaya Therapeutics (TNYA) has a market cap of $79.59M and an enterprise value of $12.80M. It kept -3356.79% of revenue as net income over the last 12 months. Its share count is up 38.36% from a year earlier.

    Total Valuation

    Enterprise value is 83.92% below the market cap, as cash exceeds debt.

    Market Cap$79.59M
    Enterprise Value$12.80M
    Latest price (Nov 17, 2026)$0.32

    Key Dates

    The next earnings report is expected on Mar 4, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 4, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 3.88% in the quarter ended Sep 30, 2026 and grew 61.96% a year over 2 years.

    Shares Outstanding226.01M
    Shares Change (YoY)+38.36%
    Shares Change (QoQ)+3.88%
    Share Count Growth (2Y CAGR)+61.96%

    Valuation Ratios

    Forward P/S20.7x
    P/B Ratio1.3x

    Price Statistics

    The stock is down 75.73% over 52 weeks and trades 34.69% below its 50-day average.

    Beta (1Y)2.70
    52-Week Change-75.73%
    1-Month Change-14.51%
    3-Month Change-54.72%
    6-Month Change-59.01%
    5-Year Change-98.57%
    Total Return (1Y)-75.73%
    Total Return (3Y CAGR)-44.41%
    Total Return (5Y CAGR)-56.75%
    Max Drawdown (1Y)-77.59%
    Max Drawdown (3Y)-95.35%
    Sharpe Ratio (1Y)-1.36
    Correlation with SPY (1Y)0.37
    50-Day Average$0.49
    200-Day Average$0.69
    52-Week Range$0.30 to $1.46
    RSI (14 Days)33.1
    Average Volume (20 Days)2.49M

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.78x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio3.78x
    Quick Ratio3.78x
    Debt / Equity0.00x

    Returns and Efficiency

    ROE (5Y Average)-71.82%
    ROA (5Y Average)-58.91%
    Asset Turnover0.03x

    Scores

    TNYA has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.

    Piotroski F-Score1 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $3.03M over the last 12 months.

    Revenue$3.03M
    Gross Profit$6.98M
    Operating Income-$104.50M
    Pretax Income-$101.78M
    Net Income-$101.78M
    EBITDA-$98.22M
    Reported EPS (TTM)-$0.38

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 71.10% of the $76.68M in total assets.

    Cash and Equivalents$66.80M
    Total Debt$0
    Net Cash$66.80M
    Net Cash Per Share$0.30
    Working Capital$52.21M
    Shareholder Equity$54.52M
    Book Value Per Share$0.24
    Total Assets$76.68M
    Total Liabilities$22.16M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$54.41M
    FCF Per Share-$0.24
    Depreciation and Amortization$5.65M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -3446.57%.

    Gross Margin230.21%
    Operating Margin-3446.57%
    Pretax Margin-3356.79%
    Net Margin-3356.79%
    EBITDA Margin-3239.48%

    Growth

    Book Value Per Share Growth (2Y CAGR)-37.16%
    Tangible Book Per Share Growth (2Y CAGR)-37.16%

    Revenue and profit by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About TNYA

    What is TNYA's market cap?

    Tenaya Therapeutics has a market cap of $79.59M. Its enterprise value, which adds debt and subtracts cash, is $12.80M.

    How many shares of TNYA are outstanding?

    Tenaya Therapeutics has 226.01M shares outstanding. The count is up 38.36% from a year earlier.

    Does TNYA pay a dividend?

    No. Tenaya Therapeutics does not pay a dividend.

    How much debt does TNYA have?

    Tenaya Therapeutics has $0 of total debt and $66.80M of cash and equivalents, a net cash position of $66.80M.